Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modeling

BACKGROUND: Two methods combining survival and health-related quality of life (HRQoL) data in glioma trials to calculate the “net clinical benefit” were evaluated: Quality-adjusted effect sizes (QASES) and joint modeling (JM). METHODS: The net clinical benefit in two trials was calculated as proof o...

Descripción completa

Detalles Bibliográficos
Autores principales: Coomans, Marijke B, Dirven, Linda, Aaronson, Neil K, Baumert, Brigitta G, van den Bent, Martin, Bottomley, Andrew, Brandes, Alba A, Chinot, Olivier, Coens, Corneel, Gorlia, Thierry, Herrlinger, Ulrich, Keime-Guibert, Florence, Malmström, Annika, Martinelli, Francesca, Sloan, Jeff A, Stupp, Roger, Talacchi, Andrea, Weller, Michael, Wick, Wolfgang, Reijneveld, Jaap C, Taphoorn, Martin J B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772555/
https://www.ncbi.nlm.nih.gov/pubmed/33409496
http://dx.doi.org/10.1093/noajnl/vdaa147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772555/
https://www.ncbi.nlm.nih.gov/pubmed/33409496
http://dx.doi.org/10.1093/noajnl/vdaa147

Ejemplares similares